April 2021
2025 February
- MO
- TU
- WE
- TH
- FR
- SA
- SU
- 24
- 25
- 26
- 27
- 28
- 1
- 2
- 3
Living Well Survey Opens
- 4
CPNI CU#250204A: Rolled Over Concessionary Prices for February 2025
- 5
- 6
2nd Submission of January Prescriptions
CPNI CU#250206A: LIVING WELL PHARMACIES ONLY: SURVEY REMINDER
CPNI CU#250206B: PSNI Consultation: Fees
- 7
CPNI CU#250207C: Weekly Summary
CPNI CU#250207A: Request for Information – NMW/NLW and Employer NIC Costs 2025/26
CPNI CU#250207B: REMINDER Completion of Care Home Visits
- 8
- 9
- 10
- 11
- 12
- 13
- 14
CPNI CU#250214A: Updates on Independent Prescribing in Community Pharmacy
CPNI CU#250214B: First Concessionary Prices – February 2025
CPNI CU#250214C: Weekly Summary
- 15
- 16
- 17
CPNI CU#240217A: LIVING WELL PHARMACIES ONLY: SURVEY REMINDER
- 18
CPNI CU#250218A: CPNI at the Northern Ireland Committee for Health Thursday 6th March 2025 – Contractor Engagement
CPNI CU#250218B: Second Concessionary Prices – February 2025
- 19
- 20
CPNI CU#250220A: Contractor Survey – To Help Brief the Committee for Health
- 21
1st Submission of February Prescriptions
CPNI CU#250221A: Weekly Summary
- 22
- 23
- 24
CPNI CU#250224A: Contractor Survey – To Help Brief the Committee for Health *** R E M I N D E R ***
- 25
- 26
CPNI CU#250226A: SPPG Correspondence Regarding The End Of The Autumn 2024 COVID-19 Programme
- 27
CPNI CU#250227A: Third Concessionary Prices – February 2025
CPNI CU#250227B: Contractor Survey – To Help Brief the Committee for Health *** LAST OPPORTUNITY ***
CPNI CU#250227C: SSP079 Estradot® 50mcg patches: expiry date extension
- 28
CPNI CU#250228A: Fourth Concessionary Prices – February 2025
CPNI CU#250228B: Weekly Summary
- 1
- 2
April Notes
- Book COVID vaccination for Pharmacy Staff info here.
- Book COVID-19 test for staff here.
- COVID-19 Checklist & Guidance for CPs to consider when closing during a pandemic here.
- Submit weekly Sit-Rep (by 12pm every Monday) here.
- Submit weekly COVID-19 CPVS Wastage Report (by 4pm every Monday) here.
- Return completed contract for Care Home Pandemic Support Service to local office info here.
- Re-order Monthly PPE using Appendix 1.
Contact Details for Local Integrated Care Offices (HSCB)
- Combination anti-platelet therapy for patients who have a coronary stent 28 April 2021
- Appendix A - DAPT Patient Letter 28 April 2021
- Appendix B - DAPT Professional Staff Information Leaflet 28 April 2021
- End of 2020/21 Flu Season and Related Issues 23 April 2021
- Living Well Campaign 2 and Campaign 3 Reminder 22 April 2021
- Resumption of Probity Processes 22 April 2021
- Potential Diversion of Oromucosal Buprenorphine (Espranor) 22 April 2021
- REMINDER - Lateral Flow Tests for Primary Care Staff - Registration 28 April 2021
- Update 17 - COVID - CPVS - Update to Eligible Cohorts 26 April 2021
- Update 16 - COVID - CPVS - Refrigerator Failure and March Payment Arrangements 13 April 2021
- Update 15 - COVID - CPVS - Limited Further Supply of AZ Vaccine 13 April 2021
- Update 14 - COVID-CPVS Update to Eligible Cohorts and JCVI Guidance 8 April 2021
- Update 13 - COVID - CPVS VMS Update 1 April 2021
- MHRA and JCVI Announcement - AZ Vaccine Updated Contraindications 29 April 2021
- COVID-19 Vaccination Protocol for Pfizer Vaccine (version 1.0a) 28 April 2021
- JCVI Announcement Regarding COVID-19 Vaccination During Pregnancy 27 April 2021
- Vaccination Protocol for COVID-19 Vaccine (Pfizer) and (AstraZeneca) 27 April 2021
- COVID-19 Vaccination Protocol for AstraZeneca Vaccine (version 1.1) 27 April 2021
- COVID-19 VACCINE ASTRAZENECA AND THROMBOEMBOLIC EVENTS WITH CONCURRENT LOW PLATELET COUNTS 8 April 2021
- Updates available here.
- A DAY IN THE LIFE OF A GENERAL PRACTICE PHARMACIST 20 April 2021
- C.W. YOUNG FUNDING REOPENED FOR APPLICATIONS 2 April 2021
- 24/7 HEALTH & WELLBEING SUPPORT FOR PHARMACY TEAM RELAUNCHED 2 April 2021
- SUCCESSFUL START FOR DIVERSITY & INCLUSION WEBINAR SERIES 2 April 2021
Drug Alerts and Shortages
Please report problems experienced in obtaining medicines to CPNI via our Medicine Shortage Reporter. This includes generic items and branded medicines.